Publications | Lund University Publications

101 – 110 of 126

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%221078-0432%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
9
10
11
12
13
next »

2006
Mark Basoluminal carcinoma: A new biologically and prognostically distinct entity between basal and luminal breast cancer
Laakso, Mervi ; Tanner, Minna ; Nilsson, Jonas ; Wiklund, Tom ; Erikstein, Bjoern ; Kellokumpu-Lehtinen, Pirkko ; Malmström, Per ^LU ; Wilking, Nils ; Bergh, Jonas and Isola, Jorma (2006) In Clinical Cancer Research 12(14). p.4185-4191
- Contribution to journal › Article
Mark Low-dose combretastatin A4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma
Badn, Wiaam ^LU ; Kalliomäki, Suzanne ^LU ; Widegren, Bengt ^LU and Sjögren, Hans Olov ^LU (2006) In Clinical Cancer Research 12(15). p.4714-4719
- Contribution to journal › Article
Mark CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance
Brennan, Donal J. ; Jirström, Karin ^LU ; Kronblad, Åsa ^LU ; Millikan, Robert C. ; Landberg, Göran ^LU ; Duffy, Michael J. ; Rydén, Lisa ^LU ; Gallagher, William M. and O'Brien, Sallyann L. (2006) In Clinical Cancer Research 12(21). p.6421-6431
- Contribution to journal › Article
Mark High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.
Stendahl, Maria ^LU ; Rydén, Lisa ^LU ; Nordenskjöld, Bo ; Jönsson, Per Ebbe ; Landberg, Göran ^LU and Jirström, Karin ^LU (2006) In Clinical Cancer Research 12(15). p.4614-4618
- Contribution to journal › Article
2005
Mark Translational crossroads for biomarkers
Bast, Robert C Jr ; Lilja, Hans ^LU ; Urban, Nicole ; Rimm, David L ; Fritsche, Herbert ; Gray, Joe ; Veltri, Robert ; Klee, George ; Allen, Andrew and Kim, Nam , et al. (2005) In Clinical Cancer Research 11(17). p.6103-6108
- Contribution to journal › Article
Mark Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival
Sand-Dejmek, Janna ^LU ; Leandersson, Karin ^LU ; Manjer, Jonas ^LU ; Bjartell, Anders ^LU ; Emdin, S O ; Vogel, WF ; Landberg, Göran ^LU and Andersson, Tommy ^LU (2005) In Clinical Cancer Research 11(2). p.520-528
- Contribution to journal › Article
Mark Dose-Fractionated Radioimmunotherapy in Non-Hodgkin's Lymphoma Using DOTA-Conjugated, 90Y-Radiolabeled, Humanized Anti-CD22 Monoclonal Antibody, Epratuzumab.
Lindén, Ola ^LU ; Hindorf, Cecilia ^LU ; Cavallin-Ståhl, Eva ^LU ; Wegener, William A ; Goldenberg, David M ; Horne, Heather ; Ohlsson, Tomas G ^LU ; Stenberg, Lars ^LU ; Strand, Sven-Erik ^LU and Tennvall, Jan ^LU (2005) In Clinical Cancer Research 11(14). p.5215-5222
- Contribution to journal › Article
Mark Blood pharmacokinetics of various monoclonal antibodies labeled with a new trifunctional chelating reagent for simultaneous conjugation with 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and biotin before radiolabeling.
Wang, Zhongmin ^LU ; Mårtensson, Linda ^LU ; Nilsson, Rune ^LU ; Bendahl, Pär-Ola ^LU ; Lindgren, Lars ; Ohlsson, Tomas G ^LU ; Sjögren, Hans Olov ^LU ; Strand, Sven-Erik ^LU and Tennvall, Jan ^LU (2005) In Clinical Cancer Research 11(19 Pt 2). p.7171-7177
- Contribution to journal › Article
Mark Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy.
Mårtensson, Linda ^LU ; Wang, Zhongmin ^LU ; Nilsson, Rune ; Ohlsson, Tomas G ^LU ; Senter, Peter ; Sjögren, Hans Olov ^LU ; Strand, Sven-Erik ^LU and Tennvall, Jan ^LU (2005) In Clinical Cancer Research 11(19 Pt 2). p.7104-7108
- Contribution to journal › Article
Mark Down-regulation of S100C is associated with bladder cancer progression and poor survival
Memon, Ashfaque Ahmed ^LU ; Sorensen, Boe Sandahl ; Meldgaard, Peter ; Fokdal, Lars ; Thykjaer, Thomas and Nexo, Ebba (2005) In Clinical Cancer Research 11(2 Pt 1). p.11-606
- Contribution to journal › Article

« previous
1
…
9
10
11
12
13
next »

your query:: Remove issn: 1078-0432